Phibro Animal Health Corporation
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Phibro Animal Health Corporation's yearly results (2023–2026), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Debt, after subtracting cash, equals 44% of its market value (net debt). Lower than 91% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Jun 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$157Over the last 3 years, every $100 of reported profit came with $157 of operating cash.
Higher than 55% of Healthcare companies in United States.
Self-Funding Ratio
1.7×Over the last 3 years its own operating cash covered its investment spending (capex) 1.7 times.
Higher than 72% of Healthcare companies in United States.
Cash Locked Ratio
$41For every $100 of sales, $41 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $37 tied up three years earlier.
More money tied up than 83% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
$12Sales grew 55% in 3 years; of every extra $100 of sales, $12 became extra profit.
Lower than 57% of Healthcare companies in United States.
Asset Productivity Ratio
+55% / +55%In 3 years sales changed by +55% while total assets changed by +55%. Both moved at about the same pace.
Balance-sheet strength
Debt Due Cover Ratio
2.8×Debt due within a year is covered 2.8 times by its yearly operating cash.
Higher than 76% of Healthcare companies in United States.
Cash Cushion Ratio
−44%Debt, after subtracting cash, equals 44% of its market value (net debt).
Lower than 91% of Healthcare companies in United States.
Tangible Assets Ratio
94%Of every $100 the company owns, $94 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 69% of Healthcare companies in United States.
Tangible Net Worth Ratio
77%Of every $100 of net worth, $77 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 59% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Phibro Animal Health Corporation owes $0.74 for every $1 it owns. Net profit rose 107% in the year to Jun 2026, and grew 45% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Jun 2026.
P/E ratio
16.4Investors pay $16.4 for every $1 of Phibro Animal Health Corporation's yearly profit, lower than 71% of Healthcare companies in United States.
P/B ratio
4.19The share price is 4.19 times Phibro Animal Health Corporation's book value per share, higher than 67% of Healthcare companies in United States.
Market cap
$1.6 BThe total market value of all of Phibro Animal Health Corporation's shares at today's price (share price × number of shares), larger than 70% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$385 MWhat Phibro Animal Health Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$9.49Net worth divided by the number of shares. The share price of $39.81 is 4.2 times this, which is the P/B above.
Return on equity (ROE)
29.7%Phibro Animal Health Corporation earned 29.7% on its shareholders' money over the last year, higher than 94% of Healthcare companies in United States.
Owes vs Owns
0.74×Phibro Animal Health Corporation owes $0.74 for every $1 it owns (moderate), higher than 74% of Healthcare companies in United States.
Dividend yield
1.22%Phibro Animal Health Corporation pays 1.22% of its share price as dividends a year, higher than 59% of dividend-paying Healthcare companies in United States.
Revenue growth
+17%Revenue rose 17% in the year to Jun 2026, and grew 16% a year on average over 3 years.
Profit growth
+107%Net profit rose 107% in the year to Jun 2026, and grew 45% a year on average over 3 years.
Profit margin
6.6%Phibro Animal Health Corporation keeps $7 of every $100 of revenue as net profit.
Cash quality
0.7×Cash from Phibro Animal Health Corporation's business was 0.7× its reported profit in the year to Jun 2026 — less cash came in than the profit reported.
Interest cover
4.4×Phibro Animal Health Corporation's operating profit covered its interest costs 4.4 times in the year to Jun 2026.
Cash vs debt
Net debtPhibro Animal Health Corporation had $707 M more debt than cash (net debt) at Jun 2026.
Questions
What is Phibro Animal Health Corporation's P/E ratio?
Investors pay $16.4 for every $1 of Phibro Animal Health Corporation's yearly profit, lower than 71% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Phibro Animal Health Corporation: $1.6 B ÷ $385 M (30 Jun 2026) = 4.2.
What is Phibro Animal Health Corporation's return on equity?
Phibro Animal Health Corporation earned 29.7% on its shareholders' money over the last year, higher than 94% of Healthcare companies in United States.
How much does Phibro Animal Health Corporation owe compared with what it owns?
Phibro Animal Health Corporation owes $0.74 for every $1 it owns (moderate), higher than 74% of Healthcare companies in United States.
Does Phibro Animal Health Corporation pay a dividend?
Yes. Phibro Animal Health Corporation pays 1.22% of its share price as dividends a year, higher than 59% of dividend-paying Healthcare companies in United States.
Is Phibro Animal Health Corporation's revenue growing?
Revenue rose 17% in the year to Jun 2026, and grew 16% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.